Dyne Therapeutics's total assets for Q1 2025 were $721.07M, an increase of 4.32% from the previous quarter. DYN total liabilities were $52.10M for the fiscal quarter, a -15.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.